3SBio Cash and Equivalents
3SBio Cash and Equivalents Chart
View Cash and Equivalents for SSRX.
Start Your YCharts Pro Platinum Membership.
3SBio Historical Cash and Equivalents Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
About Cash and Equivalents
Cash and equivalents is cash or cash equivalents that a company possesses at any given time. Examples of cash equivalents are: money market accounts, treasury bills, and short term government bonds. Cash and cash equivalents are a business' most liquid assets. Cash on hand results from a positive cash flow statement.
Investors look at cash on hand as a reflection of a company's solvency and liquidity.
Learn More
View Cash and Equivalents for SSRX.
Start Your YCharts Pro Platinum Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $199/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Platinum Member? Sign in here.
SSRX Cash and Equivalents Benchmarks
| Companies | |
|---|---|
| Antares Pharma | Go Pro |
| Celsion Corporation | Go Pro |
| Omeros Corporation | Go Pro |
SSRX Cash and Equivalents Rankings
| Overall |
72nd percentile 2198 of 8002 |
| Sector |
71st percentile 183 of 650 in Healthcare |
| Industry |
77th percentile 53 of 237 in Biotechnology |
SSRX Cash and Equivalents Range, Past 5 Years
| Minimum | Go Pro | Sep 2010 |
| Maximum | Go Pro | Jun 2008 |
| Average | Go Pro |
